OBJECTIVES: To determine whether advance care planning influences quality of end-of-life care. DESIGN: In this observational cohort study, Medicare data and survey data from the Health and Retirement Study (HRS) were combined to determine whether advance care planning was associated with quality metrics. SETTING: The nationally representative HRS. PARTICIPANTS: Four thousand three hundred ninety-nine decedent subjects (mean age 82.6 at death, 55% women). MEASUREMENTS: Advance care planning (ACP) was defined as having an advance directive (AD), durable power of attorney (DPOA) or having discussed preferences for end-of-life care with a next of kin. Outcomes included previously reported quality metrics observed during the last month of life (rates of hospital admission, in-hospital death, >14 days in the hospital, intensive care unit admission, >1 emergency department visit, hospice admission, and length of hospice ≤ 3 days). RESULTS: Seventy-six percent of subjects engaged in ACP. Ninety-two percent of ADs stated a preference to prioritize comfort. After adjustment, subjects who engaged in ACP were less likely to die in a hospital (adjusted relative risk (aRR) = 0.87, 95% confidence interval (CI) = 0.80-0.94), more likely to be enrolled in hospice (aRR = 1.68, 95% CI = 1.43-1.97), and less likely to receive hospice for 3 days or less before death (aRR = 0.88, 95% CI = 0.85-0.91). Having an AD, a DPOA or an ACP discussion were each independently associated with a significant increase in hospice use (P < .01 for all). CONCLUSION: ACP was associated with improved quality of care at the end of life, including less in-hospital death and increased use of hospice. Having an AD, assigning a DPOA and conducting ACP discussions are all important elements of ACP.
OBJECTIVES: To determine whether advance care planning influences quality of end-of-life care. DESIGN: In this observational cohort study, Medicare data and survey data from the Health and Retirement Study (HRS) were combined to determine whether advance care planning was associated with quality metrics. SETTING: The nationally representative HRS. PARTICIPANTS: Four thousand three hundred ninety-nine decedent subjects (mean age 82.6 at death, 55% women). MEASUREMENTS: Advance care planning (ACP) was defined as having an advance directive (AD), durable power of attorney (DPOA) or having discussed preferences for end-of-life care with a next of kin. Outcomes included previously reported quality metrics observed during the last month of life (rates of hospital admission, in-hospital death, >14 days in the hospital, intensive care unit admission, >1 emergency department visit, hospice admission, and length of hospice ≤ 3 days). RESULTS: Seventy-six percent of subjects engaged in ACP. Ninety-two percent of ADs stated a preference to prioritize comfort. After adjustment, subjects who engaged in ACP were less likely to die in a hospital (adjusted relative risk (aRR) = 0.87, 95% confidence interval (CI) = 0.80-0.94), more likely to be enrolled in hospice (aRR = 1.68, 95% CI = 1.43-1.97), and less likely to receive hospice for 3 days or less before death (aRR = 0.88, 95% CI = 0.85-0.91). Having an AD, a DPOA or an ACP discussion were each independently associated with a significant increase in hospice use (P < .01 for all). CONCLUSION:ACP was associated with improved quality of care at the end of life, including less in-hospital death and increased use of hospice. Having an AD, assigning a DPOA and conducting ACP discussions are all important elements of ACP.
Authors: Craig C Earle; Elyse R Park; Bonnie Lai; Jane C Weeks; John Z Ayanian; Susan Block Journal: J Clin Oncol Date: 2003-03-15 Impact factor: 44.544
Authors: Joan M Teno; Brian R Clarridge; Virginia Casey; Lisa C Welch; Terrie Wetle; Renee Shield; Vincent Mor Journal: JAMA Date: 2004-01-07 Impact factor: 56.272
Authors: Allan J Walkey; Amber E Barnato; Seppo T Rinne; Colin R Cooke; Meng-Shiou Shieh; Penelope S Pekow; Peter K Lindenauer Journal: Ann Am Thorac Soc Date: 2017-09
Authors: Anna Kata; Irena Cenzer; Rebecca L Sudore; Kenneth E Covinsky; Victoria L Tang Journal: J Gen Intern Med Date: 2020-05-04 Impact factor: 5.128
Authors: Amy S Kelley; Kenneth M Langa; Alexander K Smith; John Cagle; Katherine Ornstein; Maria J Silveira; Lauren Nicholas; Kenneth E Covinsky; Christine S Ritchie Journal: J Palliat Med Date: 2014-04-02 Impact factor: 2.947
Authors: Alison E Turnbull; Jenna R Krall; A Parker Ruhl; J Randall Curtis; Scott D Halpern; Bryan M Lau; Dale M Needham Journal: Crit Care Med Date: 2014-06 Impact factor: 7.598
Authors: Melissa M Garrido; Tracy A Balboni; Paul K Maciejewski; Yuhua Bao; Holly G Prigerson Journal: J Pain Symptom Manage Date: 2014-12-11 Impact factor: 3.612
Authors: Hillary D Lum; Jacqueline Jones; Daniel D Matlock; Russell E Glasgow; Ingrid Lobo; Cari R Levy; Robert S Schwartz; Rebecca L Sudore; Jean S Kutner Journal: Ann Fam Med Date: 2016-03 Impact factor: 5.166